» Articles » PMID: 38288418

The Benefits of Using Platelet-rich Plasma with Dermal Substitutes for Extremity Posttraumatic Skin Defects: A Short-term Outcome

Overview
Specialty General Surgery
Date 2024 Jan 30
PMID 38288418
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Skin injuries are very common. Skin grafting is an ongoing wound management procedure. The artificial dermis, PELNAC, has been considered in the treatment of several acute and chronic skin injuries. Platelet-rich plasma (PRP) is blood plasma with a platelet count higher than the baseline. It is presumed to act in a synergetic pattern to promote the healing of wounds. This study was conducted to assess the potential benefit of adding PRP to PELNAC as adjuvant therapy in treating posttraumatic skin.

Methods: In this study, adult patients who were admitted to the hospital with extremity traumatic skin and soft tissue defects with exposed bare bone, exposed tendons, or exposed cartilage in the period between October 2019 and March 2021 were allocated to either being managed with dermal substitute (PELNAC) together with PRP (group I) or PELNAC alone (group II).

Results: Patients in group I showed a higher mean graft take rate and a lower mean time for neovascularization of the acellular dermal matrix, with a statistically highly significant difference. The Vancouver Scar Scale values showed no significant difference in either group. The PRP-treated group showed statistically significant shorter hospital stays.

Conclusions: The addition of PRP to the treatment protocol showed better outcomes in terms of graft take rate, time for neovascularization of acellular dermal matrix, and length of hospital stay, with no side effects. The present study findings emphasize the promising outcome of PRP in addition to the standard treatment of complex wounds to achieve rapid and safe healing.

Citing Articles

Highly concentrated collagen/chondroitin sulfate scaffold with platelet-rich plasma promotes bone-exposed wound healing in porcine.

Li Z, Li Q, Ahmad A, Yue Z, Wang H, Wu G Front Bioeng Biotechnol. 2024; 12:1441053.

PMID: 39380894 PMC: 11458455. DOI: 10.3389/fbioe.2024.1441053.


The Application of Blood Products in Plastic Surgery: A Systematic Review.

Zhuang J, Chen Y, Zheng X, Wang C, Hu J, Liu T Plast Reconstr Surg Glob Open. 2024; 12(7):e6005.

PMID: 39050033 PMC: 11268820. DOI: 10.1097/GOX.0000000000006005.

References
1.
Park Y, Lee I, Park E, Kim J . Hydrogel and Platelet-Rich Plasma Combined Treatment to Accelerate Wound Healing in a Nude Mouse Model. Arch Plast Surg. 2017; 44(3):194-201. PMC: 5447528. DOI: 10.5999/aps.2017.44.3.194. View

2.
Ucar O, Celik S . Comparison of platelet-rich plasma gel in the care of the pressure ulcers with the dressing with serum physiology in terms of healing process and dressing costs. Int Wound J. 2020; 17(3):831-841. PMC: 7948873. DOI: 10.1111/iwj.13344. View

3.
Anitua E, Sanchez M, Orive G, Andia I . The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007; 28(31):4551-60. DOI: 10.1016/j.biomaterials.2007.06.037. View

4.
Suh H, Hong J . The role of reconstructive microsurgery in treating lower-extremity chronic wounds. Int Wound J. 2019; 16(4):951-959. PMC: 7949270. DOI: 10.1111/iwj.13127. View

5.
Eppley B, Pietrzak W, Blanton M . Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg. 2006; 118(6):147e-159e. DOI: 10.1097/01.prs.0000239606.92676.cf. View